AVITA Medical, Inc.
AVITA Medical, Inc. (RCEL) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
rcel · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for AVITA Medical, Inc. (RCEL) measures how much investors pay for each dollar of the company's trailing earnings. RCEL's current PE ratio of N/A is calculated by dividing its stock price of $4.17 by its TTM earnings per share of -$0.15.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2007 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
AVITA Medical, Inc.You RCEL | $103M | N/A | — | -$0.15 |
 Apyx Medical Corporation APYX | $201M | N/A | — | -$0.27 |
 FONAR Corporation FONR | $118M | 11.34x | — | $1.32 |
 Hyperfine, Inc. HYPR | $119M | N/A | — | -$0.38 |
 Lucid Diagnostics Inc. LUCD | $101M | N/A | — | -$0.57 |
 InspireMD, Inc. NSPR | $40M | N/A | — | -$0.66 |
 Ovid Therapeutics Inc. OVID | $320M | N/A | — | -$0.24 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.74 | — | |
2024-12-31 FY2024 | — | $-2.39 | — | |
2023-12-31 FY2023 | — | $-1.40 | — | |
2022-12-31 FY2022 | — | $-1.07 | — | |
2021-12-31 FY2021 | — | $-1.03 | — | |
2021-06-30 FY2021 | — | $-1.31 | — | |
2020-06-30 FY2020 | — | $-2.07 | — | |
2019-06-30 FY2019 | — | $-1.61 | — | |
2018-06-30 FY2018 | — | $-2.51 | — | |
2017-06-30 FY2017 | — | $-2.25 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for AVITA Medical, Inc. (RCEL) measures how much investors pay for each dollar of the company's trailing earnings. RCEL's current PE ratio of N/A is calculated by dividing its stock price of $4.17 by its TTM earnings per share of -$0.15.
Frequently asked questions
RCEL pe ratio · 6 questionsRCEL's current PE ratio is N/A as of 2026-06-09, based on a stock price of $4.17 and TTM EPS of -$0.15. Data sourced from Financial Modeling Prep via RCEL's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · AVITA Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09